The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor Injection

Clinical trial NCT02412319 · UNKNOWN

Trial details

NCT number: NCT02412319
Sponsor: Shineway Pharmaceutical Co.,Ltd
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

HBeAg Positive Chronic Hepatitis B

Start date: 2014-10-01
Primary completion: 2016-12-01
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.